The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Benkhoucha, Mahdia ^a,b   Molnarfi, Nicolas ^a,b   Schneiter, Gregory ^a,b   Walker, Paul R ^b   Lalive, Patrice H ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Central nervous system autoimmunity; Cytotoxic T lymphocytes (CTL); Dendritic cells; Hepatocyte growth factor (HGF); Immune modulation; Immunological tolerance; Multiple sclerosis (MS)

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; GLYCOPROTEIN GP 100; GRANZYME B; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; SCATTER FACTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTOTOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PROTEIN ANALYSIS; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HUMANS; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84890285948     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-154     Document Type: Article

References (43)

1. McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007, 8:913-919. 10.1038/ni1507, 17712344.
2. Mars LT, Saikali P, Liblau RS, Arbour N. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim Biophys Acta 2011, 1812:151-161. 10.1016/j.bbadis.2010.07.006, 20637863.
3. Zozulya AL, Wiendl H. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum Immunol 2008, 69:797-804. 10.1016/j.humimm.2008.07.014, 18723060.
4. Mars LT, Bauer J, Gross DA, Bucciarelli F, Firat H, Hudrisier D, Lemonnier F, Kosmatopoulos K, Liblau RS. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J Immunol 2007, 179:5090-5098.
5. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 2001, 194:669-676. 10.1084/jem.194.5.669, 2195947, 11535634.
6. Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, Wekerle H, Raine CS. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001, 166:7579-7587.
7. Friese MA, Jakobsen KB, Friis L, Etzensperger R, Craner MJ, McMahon RM, Jensen LT, Huygelen V, Jones EY, Bell JI, Fugger L. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med 2008, 14:1227-1235. 10.1038/nm.1881, 18953350.
8. Na SY, Cao Y, Toben C, Nitschke L, Stadelmann C, Gold R, Schimpl A, Hunig T. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 2008, 131:2353-2365. 10.1093/brain/awn148, 18669487.
9. Saxena A, Bauer J, Scheikl T, Zappulla J, Audebert M, Desbois S, Waisman A, Lassmann H, Liblau RS, Mars LT. Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol 2008, 181:1617-1621.
10. Sobottka B, Harrer MD, Ziegler U, Fischer K, Wiendl H, Hunig T, Becher B, Goebels N. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. Am J Pathol 2009, 175:1160-1166. 10.2353/ajpath.2009.090340, 2731134, 19700745.
11. Friese MA, Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?. Brain 2005, 128:1747-1763. 10.1093/brain/awh578, 15975943.
12. Bailey SL, Schreiner B, McMahon EJ, Miller SD. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol 2007, 8:172-180. 10.1038/ni1430, 17206145.
13. Ji Q, Castelli L, Goverman JM. MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells. Nat Immunol 2013, 14:254-261. 10.1038/ni.2513, 3581685, 23291597.
14. Li H, Zhang GX, Chen Y, Xu H, Fitzgerald DC, Zhao Z, Rostami A. CD11c + CD11b + dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis. J Immunol 2008, 181:2483-2493. 2676731, 18684939.
15. Pulendran B, Tang H, Manicassamy S. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol 2010, 11:647-655. 10.1038/ni.1894, 20644570.
16. Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, Matsumoto K, Miyazaki J, Nakamura T, Yamamoto K. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 2005, 175:4745-4753.
17. Futamatsu H, Suzuki J, Mizuno S, Koga N, Adachi S, Kosuge H, Maejima Y, Hirao K, Nakamura T, Isobe M. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res 2005, 96:823-830. 10.1161/01.RES.0000163016.52653.2e, 15774858.
18. Kuroiwa T, Iwasaki T, Imado T, Sekiguchi M, Fujimoto J, Sano H. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther 2006, 8:R123. 10.1186/ar2012, 1779408, 16859527.
19. Okunishi K, Dohi M, Fujio K, Nakagome K, Tabata Y, Okasora T, Seki M, Shibuya M, Imamura M, Harada H, Tanaka R, Yamamoto K. Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol 2007, 179:5504-5513.
20. Benkhoucha M, Santiago-Raber ML, Schneiter G, Chofflon M, Funakoshi H, Nakamura T, Lalive PH. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25 + Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 2010, 107:6424-6429. 10.1073/pnas.0912437107, 2851995, 20332205.
21. Rutella S, Bonanno G, Procoli A, Mariotti A, de Ritis DG, Curti A, Danese S, Pessina G, Pandolfi S, Natoni F, Di Febo A, Scambia G, Manfredini R, Salati S, Ferrari S, Pierelli L, Leone G, Lemoli RM. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006, 108:218-227. 10.1182/blood-2005-08-3141, 16527888.
22. Lalive PH, Paglinawan R, Biollaz G, Kappos EA, Leone DP, Malipiero U, Relvas JB, Moransard M, Suter T, Fontana A. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. Eur J Immunol 2005, 35:727-737. 10.1002/eji.200425430, 15724248.
23. Molnarfi N, Benkhoucha M, Bjarnadottir K, Juillard C, Lalive PH. Interferon-beta induces hepatocyte growth factor in monocytes of multiple sclerosis patients. PLoS One 2012, 7:e49882. 10.1371/journal.pone.0049882, 3498184, 23166786.
24. Bai L, Lennon DP, Caplan AI, DeChant A, Hecker J, Kranso J, Zaremba A, Miller RH. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 2012, 15:862-879. 10.1038/nn.3109, 3427471, 22610068.
25. Deb C, Lafrance-Corey RG, Schmalstieg WF, Sauer BM, Wang H, German CL, Windebank AJ, Rodriguez M, Howe CL. CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. PLoS One 2010, 5:e12478. 10.1371/journal.pone.0012478, 2930011, 20814579.
26. Melzer N, Meuth SG, Wiendl H. CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability. FASEB J 2009, 23:3659-3673. 10.1096/fj.09-136200, 19567369.
27. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443. 10.1038/342440a0, 2531289.
28. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, Vyth-Dreese FA, Dellemijn TA, Antony PA, Spiess PJ, Palmer DC, Heimann DM, Klebanoff CA, Yu Z, Hwang LN, Feigenbaum L, Kruisbeek AM, Rosenberg SA, Restifo NP. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 2003, 198:569-580. 10.1084/jem.20030590, 2194177, 12925674.
29. Villadangos JA, Heath WR, Carbone FR. Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells. Trends Immunol 2007, 28:45-47. 10.1016/j.it.2006.12.008, 17197240.
30. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Ann Rev Immunol 1990, 8:579-621.
31. Booss J, Esiri MM, Tourtellotte WW, Mason DY. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1983, 62:219-232. 10.1016/0022-510X(83)90201-0, 6607973.
32. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 1986, 19:578-587. 10.1002/ana.410190610, 3524414.
33. Traugott U, Reinherz EL, Raine CS. Multiple sclerosis: distribution of T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 1983, 4:201-221. 10.1016/0165-5728(83)90036-X, 6222066.
34. Wong GH, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW. Inducible expression of H-2 and Ia antigens on brain cells. Nature 1984, 310:688-691. 10.1038/310688a0, 6433204.
35. Neumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science 1995, 269:549-552. 10.1126/science.7624779, 7624779.
36. Neumann H, Schmidt H, Cavalie A, Jenne D, Wekerle H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J Exp Med 1997, 185:305-316. 10.1084/jem.185.2.305, 2196130, 9016879.
37. Jacobsen M, Cepok S, Quak E, Happel M, Gaber R, Ziegler A, Schock S, Oertel WH, Sommer N, Hemmer B. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002, 125:538-550. 10.1093/brain/awf059, 11872611.
38. Junker A, Ivanidze J, Malotka J, Eiglmeier I, Lassmann H, Wekerle H, Meinl E, Hohlfeld R, Dornmair K. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 2007, 130:2789-2799. 10.1093/brain/awm214, 17890278.
39. Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002, 25:313-319. 10.1016/S0166-2236(02)02154-9, 12086750.
40. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Capello E, Mancardi GL, Aloisi F. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol 2006, 65:124-141.
41. Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007, 17:210-218. 10.1111/j.1750-3639.2007.00064.x, 17388952.
42. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996, 184:2361-2370. 10.1084/jem.184.6.2361, 2196365, 8976190.
43. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci 1997, 149:1-11. 10.1016/S0022-510X(97)05213-1, 9168159.